"Viremia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The presence of viruses in the blood.
| Descriptor ID |
D014766
|
| MeSH Number(s) |
C02.937 C23.550.470.790.500.900
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Viremia".
Below are MeSH descriptors whose meaning is more specific than "Viremia".
This graph shows the total number of publications written about "Viremia" by people in this website by year, and whether "Viremia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1996 | 0 | 2 | 2 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 5 | 5 |
| 2002 | 1 | 4 | 5 |
| 2003 | 2 | 1 | 3 |
| 2004 | 1 | 2 | 3 |
| 2005 | 0 | 3 | 3 |
| 2006 | 1 | 3 | 4 |
| 2007 | 2 | 2 | 4 |
| 2008 | 0 | 3 | 3 |
| 2009 | 0 | 3 | 3 |
| 2010 | 2 | 2 | 4 |
| 2011 | 1 | 3 | 4 |
| 2012 | 0 | 1 | 1 |
| 2013 | 2 | 1 | 3 |
| 2014 | 2 | 3 | 5 |
| 2015 | 2 | 3 | 5 |
| 2016 | 1 | 5 | 6 |
| 2017 | 0 | 1 | 1 |
| 2018 | 4 | 4 | 8 |
| 2019 | 2 | 2 | 4 |
| 2020 | 1 | 5 | 6 |
| 2021 | 0 | 1 | 1 |
| 2022 | 1 | 6 | 7 |
| 2023 | 0 | 2 | 2 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Viremia" by people in Profiles.
-
Resistance-informed versus empirical management of viraemia in children and adolescents with HIV in Lesotho and Tanzania (GIVE MOVE trial): a multisite, open-label randomised controlled trial. Lancet Glob Health. 2024 Aug; 12(8):e1312-e1322.
-
Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. J Am Soc Nephrol. 2024 May 01; 35(5):618-629.
-
Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors. Am J Gastroenterol. 2023 09 01; 118(9):1609-1617.
-
Another tool against cytomegalovirus after allogeneic hematopoietic cell transplantation. J Clin Invest. 2023 05 15; 133(10).
-
Real world experience: Examining outcomes using letermovir for CMV prophylaxis in high-risk allogeneic hematopoietic stem cell patients in the setting of using T-cell depletion as GVHD prophylaxis. Transpl Immunol. 2023 02; 76:101769.
-
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial. Clin Infect Dis. 2022 09 10; 75(4):690-701.
-
Hepatitis E Virus Infection in Cancer Patients. Transplant Cell Ther. 2022 11; 28(11):788.e1-788.e5.
-
Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency. J Clin Invest. 2022 08 01; 132(15).
-
Human immune globulin treatment controls Zika viremia in pregnant rhesus macaques. PLoS One. 2022; 17(7):e0266664.
-
A Case Series of Children with Acute Hepatitis and Human Adenovirus Infection. N Engl J Med. 2022 08 18; 387(7):620-630.